Patents by Inventor Seiichiro Ozono

Seiichiro Ozono has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Benzylamine derivative or pharmaceutically acceptable acid addition salt thereof, and use thereof for medical purposes
    Patent number: 8148427
    Abstract: The benzylamine derivative represented by the formula below and a pharmaceutically acceptable acid addition salt thereof, and a pharmaceutical containing the derivative or the pharmaceutically acceptable acid addition salt thereof, and a therapeutic or prophylactic agent for pollakiuria or urinary incontinence containing the derivative or the pharmaceutically acceptable acid addition salt thereof are provided. The benzylamine derivative of the present invention and the pharmaceutically acceptable acid addition salt thereof have less possibility of occurrence of side effects than known compounds, and show a better therapeutic effect against pollakiuria or urinary incontinence, so that they can be used as excellent therapeutic or prophylactic agents for pollakiuria or urinary incontinence.
    Type: Grant
    Filed: January 31, 2008
    Date of Patent: April 3, 2012
    Assignee: Toray Industries, Inc.
    Inventors: Ryoji Hayashi, Tsukasa Kikuchi, Masaki Arai, Satoshi Kurosawa, Ko Hasebe, Sayoko Kanie, Seiichiro Ozono, Atsushi Otsuka
  • BENZYLAMINE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALT THEREOF, AND USE THEREOF FOR MEDICAL PURPOSES
    Publication number: 20100099769
    Abstract: The benzylamine derivative represented by the formula below and a pharmaceutically acceptable acid addition salt thereof, and a pharmaceutical containing the derivative or the pharmaceutically acceptable acid addition salt thereof, and a therapeutic or prophylactic agent for pollakiuria or urinary incontinence containing the derivative or the pharmaceutically acceptable acid addition salt thereof are provided. The benzylamine derivative of the present invention and the pharmaceutically acceptable acid addition salt thereof have less possibility of occurrence of side effects than known compounds, and show a better therapeutic effect against pollakiuria or urinary incontinence, so that they can be used as excellent therapeutic or prophylactic agents for pollakiuria or urinary incontinence.
    Type: Application
    Filed: January 31, 2008
    Publication date: April 22, 2010
    Applicant: TORAY INDUSTRIES, INC.
    Inventors: Ryoji Hayashi, Tsukasa Kikuchi, Masaki Arai, Satoshi Kurosawa, Ko Hasebe, Sayoko Kanie, Seiichiro Ozono, Atsushi Otsuka